DERM
Income statement / Annual
Last year (2024), Journey Medical Corporation's total revenue was $56.13 M,
a decrease of 29.11% from the previous year.
In 2024, Journey Medical Corporation's net income was -$14.67 M.
See Journey Medical Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$56.13 M |
$79.18 M |
$73.67 M |
$63.13 M |
$44.53 M |
$34.92 M |
$42.34 M |
$4.54 M |
$22.59 M |
$7.30 M |
| Cost of Revenue |
$20.88 M
|
$26.66 M
|
$30.78 M
|
$32.08 M
|
$14.59 M
|
$10.53 M
|
$1.18 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$35.26 M
|
$52.52 M
|
$42.89 M
|
$31.05 M
|
$29.94 M
|
$24.39 M
|
$41.16 M
|
$4.54 M
|
$22.59 M
|
$7.30 M
|
| Gross Profit Ratio |
0.63
|
0.66
|
0.58
|
0.49
|
0.67
|
0.7
|
0.97
|
1
|
1
|
1
|
| Research and Development Expenses |
$9.86 M
|
$7.54 M
|
$10.94 M
|
$16.56 M
|
$0.00
|
$0.00
|
$80.55 M
|
$104.41 M
|
$83.17 M
|
$66.83 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$172.58 M
|
$71.90 M
|
$30.04 M
|
$17.72 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$40.20 M
|
$43.91 M
|
$59.47 M
|
$39.83 M
|
$22.09 M
|
$19.13 M
|
$172.58 M
|
$71.90 M
|
$30.04 M
|
$17.72 M
|
| Other Expenses |
-$1.13 M
|
$3.14 M
|
$0.00
|
$23.36 M
|
$0.00
|
$0.00
|
$2.02 M
|
$128.56 M
|
$0.00
|
$2.52 M
|
| Operating Expenses |
$48.93 M
|
$54.59 M
|
$70.41 M
|
$56.39 M
|
$22.09 M
|
$19.13 M
|
$255.15 M
|
$304.87 M
|
$113.21 M
|
$87.07 M
|
| Cost And Expenses |
$69.81 M
|
$81.25 M
|
$101.19 M
|
$88.48 M
|
$36.68 M
|
$29.66 M
|
$256.32 M
|
$304.87 M
|
$113.21 M
|
$87.07 M
|
| Interest Income |
$757,000.00
|
$322,000.00
|
$60,000.00
|
$2,000.00
|
$698,000.00
|
$255,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.70 M
|
$1.70 M
|
$2.02 M
|
$7.03 M
|
$698,000.00
|
$255,000.00
|
$15.64 M
|
$8.14 M
|
$1.54 M
|
$147,000.00
|
| Depreciation & Amortization |
$3.52 M
|
$3.86 M
|
$4.37 M
|
$2.56 M
|
$1.52 M
|
$1.21 M
|
$555,000.00
|
$339,000.00
|
$123,000.00
|
$72,000.00
|
| EBITDA |
-$8.49 M |
$1.92 M |
-$23.18 M |
-$32.77 M |
$9.37 M |
$6.44 M |
-$205.54 M |
-$294.78 M |
-$87.42 M |
-$78.80 M |
| EBITDA Ratio |
-0.15
|
0.02
|
-0.31
|
-0.52
|
0.21
|
0.18
|
-4.85
|
-64.92
|
-3.87
|
-10.79
|
| Operating Income Ratio |
-0.24
|
-0.03
|
-0.37
|
-0.4
|
0.18
|
0.15
|
-5.05
|
-66.14
|
-4.01
|
-10.93
|
| Total Other Income/Expenses Net |
-$934,000.00
|
-$1.56 M
|
-$2.05 M
|
-$7.48 M
|
-$698,000.00
|
-$255,000.00
|
-$7.75 M
|
-$2.94 M
|
$1.54 M
|
$749,000.00
|
| Income Before Tax |
-$14.61 M
|
-$3.63 M
|
-$29.57 M
|
-$42.36 M
|
$7.15 M
|
$5.00 M
|
-$221.73 M
|
-$303.26 M
|
-$89.08 M
|
-$79.02 M
|
| Income Before Tax Ratio |
-0.26
|
-0.05
|
-0.4
|
-0.67
|
0.16
|
0.14
|
-5.24
|
-66.78
|
-3.94
|
-10.82
|
| Income Tax Expense |
$61,000.00
|
$221,000.00
|
$63,000.00
|
$1.63 M
|
$1.87 M
|
$1.38 M
|
-$194,000.00
|
$5.21 M
|
$3.08 M
|
-$622,000.00
|
| Net Income |
-$14.67 M
|
-$3.85 M
|
-$29.63 M
|
-$43.99 M
|
$5.28 M
|
$3.63 M
|
-$221.54 M
|
-$303.26 M
|
-$89.08 M
|
-$78.40 M
|
| Net Income Ratio |
-0.26
|
-0.05
|
-0.4
|
-0.7
|
0.12
|
0.1
|
-5.23
|
-66.78
|
-3.94
|
-10.74
|
| EPS |
-0.72 |
-0.21 |
-1.69 |
-2.54 |
0.32 |
0.22 |
-5.27 |
-7.48 |
-2.7 |
-2.93 |
| EPS Diluted |
-0.72 |
-0.21 |
-1.69 |
-2.54 |
0.32 |
0.22 |
-5.27 |
-7.48 |
-2.7 |
-2.93 |
| Weighted Average Shares Out |
$20.43 M
|
$18.23 M
|
$17.53 M
|
$17.32 M
|
$16.66 M
|
$16.66 M
|
$42.00 M
|
$40.56 M
|
$33.04 M
|
$26.73 M
|
| Weighted Average Shares Out Diluted |
$20.43 M
|
$18.23 M
|
$17.53 M
|
$17.32 M
|
$16.66 M
|
$16.66 M
|
$42.00 M
|
$40.56 M
|
$33.04 M
|
$26.73 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
